Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.
Press releases published on April 30, 2025

Emerita Files NI 43-101 Technical Report for the IBW Project, Marking a 35% Increase in Total Indicated Resources and a 44% Increase in Total Inferred Resources
TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX – V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) reports that it has filed the independent NI 43-101 compliant technical report for its Iberian Belt West Project (“IBW” …

Sionna Therapeutics to Present at The Citizens Life Sciences Conference 2025
WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that …

10 Barrel Brewing Launches Non-Alcoholic Apocalypse IPA, a Bold Craft Brew for Your Next Adventure
BEND, Ore., April 30, 2025 (GLOBE NEWSWIRE) -- 10 Barrel Brewing, a Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY) craft beer brand, is excited to announce the launch of NA Apocalypse IPA, a non-alcoholic version of their beloved Apocalypse IPA. This …

Nusano Names Rachel Culbertson VP of Supply Chain
WEST VALLEY CITY, Utah, April 30, 2025 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of radioisotopes, today announced the appointment of Rachel Culbertson as Vice President of Supply Chain. Culbertson’s leadership will be …

ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
RAMSEY, N.J. and BOCA RATON, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing …

Akero Therapeutics Announces Upcoming Poster and Oral Presentations at the EASL Congress 2025
SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …

Larimar Therapeutics Reports First Quarter 2025 Financial Results
FDA stated as part of a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably likely surrogate endpoint in support of an accelerated approval BLA seeking accelerated approval planned to be submitted by year-end …

I-Mab Announces Givastomig Abstract Accepted for Oral Presentation at ESMO GI 2025
ROCKVILLE, Md., April 30, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that an abstract for …

HydroGraph Announces Strategic Relationship and New Texas Production Facility
TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (FRA: M98) (“HydroGraph” or the “Company”), a sustainable commercial manufacturer of pristine graphene, today announced two major growth milestones: a …

XORTX Provides Update on FDA Type B Meeting Request
● XORTX will focus on key steps to advance a NDA filing for Gout indication ● CALGARY, Alberta, April 30, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical …

Apellis Pharmaceuticals to Host Conference Call on May 7, 2025, to Discuss First Quarter 2025 Financial Results
WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its first quarter 2025 financial results on Wednesday, May 7, 2025, at 8:30 …

OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain
Urcosimod phase 2 trial treating Neuropathic Corneal Pain (“NCP”) patients was initiated in October 2024 and designed as a double-masked, randomized, 12-week placebo-controlled trial. OKYO Pharma plans to analyze the efficacy data from the 17 patients who …

Martin Marietta Reports First-Quarter 2025 Results
Pricing Momentum, Cost Discipline and Acquisition Contributions Drive Margin Expansion Double-Digit Aggregates Gross Profit Per Ton Growth Drives Record First Quarter Aggregates Profitability Magnesia Specialties Posts Quarterly Records for Revenues and …

Wabash Announces First Quarter 2025 Results
Quarterly revenue of $381 million - lower than prior quarterly outlook range on weaker Transportation Solutions demand. Parts …

CLIQ: Einladung zum Earnings Call für das erste Quartal 2025
DÜSSELDORF, 30. April 2025 – Der CLIQ-Konzern wird am Donnerstag, den 8. Mai 2025, seine Finanzergebnisse und Highlights für das erste Quartal 2025 präsentieren. Der Finanzbericht Q1 2025 und die begleitende Präsentation zum Earnings Call werden ab 7:30 …

CLIQ: Invitation to First Quarter 2025 Results Presentation
DÜSSELDORF, 30 April 2025 – The CLIQ Group will report and present its first quarter 2025 financial results and highlights on Thursday, 8 May 2025. The 1Q 2025 Financial Report and a slides deck to accompany the earnings call will be available at https:// …

Best Steroids for Sale 2025 - Buy Steroids Online Legally for Cutting and Bulking Where to Buy Legal Steroids for Sale OTC - CrazyBulk
Albany, New York, April 30, 2025 (GLOBE NEWSWIRE) -- If you are searching for steroids for sale online, CrazyBulk has an extensive range of bodybuilding steroids that are both legal to buy and great value. Steroids are known for their ability to support …

Parents say stress management most important skill kids aren’t learning
FindTutors, in partnership with GoStudent reveals that kids are struggling to cope with exam stress now more than ever This comes as referrals for anxiety in children in the UK have more than doubled since before the pandemic As Stress Awareness Month …

PL BioScience Launches World’s Only Patented Gamma-irradiated Human Platelet Lysate
New high-quality cell growth supplement for cell manufacturing applications including in regenerative medicine and cell therapies Human Platelet Lysate (HPL) offers a safer and sustainable alternative to Fetal Bovine/ Calf Serum (FBS/FCS) Gamma-irradiated …

Cybersecurity Burnout Crisis: INE Security Offers Solutions for Sustainable Cybersecurity Careers
Cary, NC, April 30, 2025 (GLOBE NEWSWIRE) -- Cybersecurity professionals are near the top of the list when it comes to career burnout. Threat landscapes are expanding and security teams are chronically understaffed, leaving many professionals working in a …